These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20431896)

  • 1. Recommendation for use of rhBMP-2 in spinal interbody fusions.
    Smoljanovic T; Aljinovic A; Bojanic I
    Eur Spine J; 2010 Aug; 19(8):1385-6; author reply 1389-91. PubMed ID: 20431896
    [No Abstract]   [Full Text] [Related]  

  • 2. The level of evidence in clinical studies of the use of rhBMP-2 in spinal interbody fusions.
    Smoljanovic T; Stipcic I; Bojanic I
    Eur Spine J; 2010 Aug; 19(8):1387-8; author reply 1389-91. PubMed ID: 20424871
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiographic and CT evaluation of recombinant human bone morphogenetic protein-2-assisted spinal interbody fusion.
    Sethi A; Craig J; Bartol S; Chen W; Jacobson M; Coe C; Vaidya R
    AJR Am J Roentgenol; 2011 Jul; 197(1):W128-33. PubMed ID: 21700973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Percutaneous Posterolateral Spinal Fusion With Recombinant Bone Morphogenetic Protein-2 (rhBMP-2): A Comparison With Standard Methods Using an Animal Model Study.
    Chan CY; Kwan MK; Saw LB; Paisal H
    Clin Spine Surg; 2017 Mar; 30(2):E138-E147. PubMed ID: 28207623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
    Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior lumbar interbody fusion using rhBMP-2.
    Heary RF
    J Neurosurg Spine; 2014 Dec; 21(6):849-50. PubMed ID: 25279656
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates.
    Schmitt PJ; Kelleher JP; Ailon T; Heller JE; Kasliwal MK; Shaffrey CI; Smith JS
    Neurosurgery; 2016 Aug; 79(2):212-21. PubMed ID: 26702838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000; 25:376-81.
    Smoljanovic T; Bojanic I; Cimic M
    Spine (Phila Pa 1976); 2010 Sep; 35(20):E1010-1011; author reply E1011. PubMed ID: 20844414
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Local Bone Remodeling Effects of rhBMP-2 in an Ovine Interbody Spine Fusion Model.
    Bae HW; Patel VV; Sardar ZM; Badura JM; Pradhan BB; Seim HB; Turner AS; Toth JM
    J Bone Joint Surg Am; 2016 Dec; 98(24):2061-2070. PubMed ID: 28002369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine 2001;26:2751-6.
    Smoljanovic T; Bicanic G; Bojanic I
    Spine (Phila Pa 1976); 2010 Sep; 35(20):E1013. PubMed ID: 20844419
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Recombinant Human Bone Morphogenetic Protein-2 in the Treatment of Degenerative Spondylolisthesis.
    Schroeder GD; Hsu WK; Kepler CK; Kurd MF; Vaccaro AR; Patel AA; Savage JW
    Spine (Phila Pa 1976); 2016 Mar; 41(5):445-9. PubMed ID: 26571176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bone morphogenetic protein-2 for adult spinal deformity.
    Luhmann SJ; Bridwell KH; Cheng I; Imamura T; Lenke LG; Schootman M
    Spine (Phila Pa 1976); 2005 Sep; 30(17 Suppl):S110-7. PubMed ID: 16138058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile for the clinical use of bone morphogenetic proteins in the spine.
    Poynton AR; Lane JM
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S40-8. PubMed ID: 12205419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.